Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DBM Corp USA appears to be the active U.S. operating company behind the MIRACU USA brand, focused on commercializing MIRACU PDO thread products and related aesthetic medical supplies in the United States. The business is a subsidiary of South Korea-based Dongbang Medical and serves as a U.S. portfolio and distribution platform for medical aesthetics and healthcare products. MIRACU is marketed as a line of absorbable polydioxanone (PDO) thread devices used in minimally invasive aesthetic procedures, with FDA 510(k) clearance history tied to the Miracu device name. The company is commercial-stage rather than a drug-development biotech, and there is no evidence of a therapeutic drug pipeline. Its business is centered on regulated aesthetic medical devices, clinician supply, and commercialization support for the U.S. market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MIRACU USA.